Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103896945A introduces an eco-friendly folic acid production method replacing low-purity trichloroacetone with stable trihalogen propylene for superior yield and supply chain reliability.
Novel metal-free electrocatalytic route for 1,4-dicarbonyl-Z olefins. High purity, green synthesis, scalable for pharma intermediates.
Patent CN102942521B details a DCC-mediated amidation route for Roflumilast intermediates offering enhanced purity and reduced equipment corrosion for supply chains.
Patent CN118344336A reveals a one-step catalytic route for high-purity thiophene derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106631702A reveals high-yield chiral phosphoric acid catalysis for SPINOL. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109574938B reveals a novel synthesis route for Rosuvastatin Sodium featuring mild conditions, high atom economy, and superior stereoselectivity for industrial scale-up.
Patent CN105111136B reveals a novel synthesis route for piperidine ketones offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel copper-catalyzed route for pyrone[3,4-b]indole derivatives. Reduces cost, simplifies scale-up for pharma intermediates.
Advanced synthesis method for high-purity deuterated celecoxib intermediate offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel synthesis method for NR chloride using TMSOTf activation. Reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Novel Rh-catalyzed one-pot synthesis for 1,9-diazaphenalene derivatives. High yield, scalable process for OLED and pharma intermediates.
Patent CN101941971B details a green synthesis of Evodiamine via catalytic hydrogenation and anhydride condensation, offering high purity and cost reduction for pharma manufacturing.
Patent CN106220586A details a metal-free synthesis of 5-amino-1,2,4-selenadiazole derivatives using selenium powder, offering high yields and supply chain reliability for pharmaceutical intermediates.
Patent CN110407739B details a high-yield, one-pot synthesis of diaryl-tetrahydropyridines. This method offers 100% atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN106467481A enables green synthesis of indole-3-aryl ketones. Visible light catalysis reduces costs and ensures reliable pharmaceutical intermediates supplier continuity.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN110330460B details a high-yield solid acid catalyzed route for p-hydroxyphenylhydantoin, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed method offers high yield and enantioselectivity for chiral intermediates. Reduces costs and simplifies supply chain for pharmaceutical manufacturing partners globally.
Novel synthesis route offers high yield and mild conditions for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency for global buyers.